KCM
BHVN
Kingdon Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-136,306
| Closed | -$16.2M | – | 94 |
|
|
2022
Q1 | $16.2M | Sell |
136,306
-164,067
| -55% | -$19.5M | 1.68% | 12 |
|
|
2021
Q4 | $41.4M | Sell |
300,373
-65,000
| -18% | -$8.96M | 4.76% | 3 |
|
|
2021
Q3 | $50.8M | Sell |
365,373
-35,633
| -9% | -$4.95M | 6.17% | 1 |
|
|
2021
Q2 | $38.9M | Sell |
401,006
-459,255
| -53% | -$44.6M | 4.51% | 3 |
|
|
2021
Q1 | $58.8M | Sell |
860,261
-370,000
| -30% | -$25.3M | 6.01% | 1 |
|
|
2020
Q4 | $105M | Sell |
1,230,261
-80,000
| -6% | -$6.86M | 11.41% | 1 |
|
|
2020
Q3 | $85.2M | Buy |
1,310,261
+8,000
| +0.6% | +$520K | 9.56% | 1 |
|
|
2020
Q2 | $95.2M | Sell |
1,302,261
-160,500
| -11% | -$11.7M | 8.66% | 1 |
|
|
2020
Q1 | $49.8M | Buy |
1,462,761
+205,041
| +16% | +$6.98M | 9.11% | 1 |
|
|
2019
Q4 | $68.5M | Buy |
1,257,720
+100,946
| +9% | +$5.5M | 10.31% | 1 |
|
|
2019
Q3 | $48.3M | Buy |
1,156,774
+155,364
| +16% | +$6.48M | 5.7% | 1 |
|
|
2019
Q2 | $43.9M | Buy |
1,001,410
+157,144
| +19% | +$6.88M | 4.31% | 1 |
|
|
2019
Q1 | $43.5M | Buy |
844,266
+173,528
| +26% | +$8.93M | 5.81% | 1 |
|
|
2018
Q4 | $24.8M | Buy |
670,738
+48,410
| +8% | +$1.79M | 3.74% | 6 |
|
|
2018
Q3 | $23.4M | Buy |
622,328
+24,732
| +4% | +$929K | 1.63% | 11 |
|
|
2018
Q2 | $23.6M | Buy |
597,596
+81,859
| +16% | +$3.24M | 1.65% | 11 |
|
|
2018
Q1 | $13.3M | Buy |
+515,737
| New | +$13.3M | 1.05% | 28 |
|